BioNTech SE - ADR

BNTX

Market Cap$20.61B

Close$

Compare BioNTech SE - ADR

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
BioNTech SE - ADR	20	0%	5%	5.3	-
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$118.75

Target Price by Analysts

32% upsideBioNTech SE - ADR Target Price Details

$-57.02

Current Fair Value

163.4% downside

Overvalued by 163.4% based on the discounted cash flow analysis.

Share Statistics

Market cap	$20.61 Billion
Enterprise Value	$7.96 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$4.24
Beta	0.0
Outstanding Shares	237,725,735
Avg 30 Day Volume	581,544

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	20.04
PEG	-25.29
Price to Sales	5.29
Price to Book Ratio	0.96
Enterprise Value to Revenue	1.89
Enterprise Value to EBIT	8.31
Enterprise Value to Net Income	7
Total Debt to Enterprise	0.03
Debt to Equity	0.01

Revenue Sources

No data

ESG Score

No data

About BioNTech SE